These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 29600961)

  • 41. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
    Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
    Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.
    Xiong M; Jiang H; Serrano JR; Gonzales ER; Wang C; Gratuze M; Hoyle R; Bien-Ly N; Silverman AP; Sullivan PM; Watts RJ; Ulrich JD; Zipfel GJ; Holtzman DM
    Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. APOE-amyloid interaction: Therapeutic targets.
    Wisniewski T; Drummond E
    Neurobiol Dis; 2020 May; 138():104784. PubMed ID: 32027932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
    Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
    Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
    Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
    J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β.
    Chai AB; Lam HHJ; Kockx M; Gelissen IC
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity Accelerates Alzheimer-Related Pathology in
    Moser VA; Pike CJ
    eNeuro; 2017; 4(3):. PubMed ID: 28612048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estradiol improves behavior in FAD transgenic mice that express
    Balu D; Valencia-Olvera AC; Deshpande A; Narayanam S; Konasani S; Pattisapu S; York JM; Thatcher GRJ; LaDu MJ; Tai LM
    Front Endocrinol (Lausanne); 2024; 15():1374825. PubMed ID: 38742194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits.
    Belinson H; Lev D; Masliah E; Michaelson DM
    J Neurosci; 2008 Apr; 28(18):4690-701. PubMed ID: 18448646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.
    Li J; Kanekiyo T; Shinohara M; Zhang Y; LaDu MJ; Xu H; Bu G
    J Biol Chem; 2012 Dec; 287(53):44593-601. PubMed ID: 23132858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. APOE4 genotype and aging impair injury-induced microglial behavior in brain slices, including toward Aβ, through P2RY12.
    Sepulveda J; Kim JY; Binder J; Vicini S; Rebeck GW
    Mol Neurodegener; 2024 Mar; 19(1):24. PubMed ID: 38468308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
    Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brain.
    Jones PB; Adams KW; Rozkalne A; Spires-Jones TL; Hshieh TT; Hashimoto T; von Armin CA; Mielke M; Bacskai BJ; Hyman BT
    PLoS One; 2011 Jan; 6(1):e14586. PubMed ID: 21297948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
    Sun YY; Wang Z; Huang HC
    Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
    Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
    Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
    Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
    Prasad H; Rao R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.